Definition of the α2 region of HLA-DR molecules involved in CD4 binding

Human Immunology

Volumn 60, Issue 4, 1999, Pages 273-281

  Gaubin, Muriel ^a   Houlgatte, Rémi ^a   Dettin, Monica ^b   Scarinci, Claudia ^b   Martin, Michelle ^a   Guardiola, John ^c   Di Bello, Carlo ^b   Piatier Tonneau, Dominique ^a  

^a CNRS   (France)

^b UNIVERSITY OF PADOVA   (Italy)

^c INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

Affinity chromatography; Circular dichroism; MHC class II CD4 interaction; Molecular modeling; Peptide synthesis

Indexed keywords

CD4 ANTIGEN; CYCLOPEPTIDE; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING SITE; CIRCULAR DICHROISM; CYCLIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIGENS, CD4; CHROMATOGRAPHY, AFFINITY; CIRCULAR DICHROISM; HLA-DR ANTIGENS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; SEPHAROSE;

EID: 0032937516     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00130-X     Document Type: Article

References (35)

1. Kaufman J.F., Strominger J.L. Both chains of HLA-DR bind to the membrane with a penultimate hydrophobic region and the heavy chain is phosphorylated at its hydrophobic carboxy terminus. Proc Natl Acad Sci USA. 76:1979;6304.
2. Shackelford D.A., Kaufman J.F., Korman A.J., Strominger J.L. HLA-DR antigens structure, separation of subpopulations, gene cloning and function . Immunol Rev. 66:1982;133.
3. Weiss A., Imbodan J., Hardy K., Manger B., Terhorst C., Stobo J. The role of the T3/antigen receptor complex in T-cell activation. Annu Rev Immunol. 4:1986;593.
4. Rudensky A.Y., Preston-Hurlburt P., Hong S.C., Barlow A., Janeway C.A.J. Sequence analysis of peptides bound to MHC class II molecules. Nature. 353:1991;622.
5. Saizawa K., Rojo J., Janeway C.A.J. Evidence for a physical association of CD4 and CD3 α: β T cell receptor . Nature. 328:1987;260.
6. Anderson P., Blue M.L., Morimoto C., Schlossman S.F. Cross-linking of T3 (CD3) with T4 (CD4) enhances the proliferation of resting T lymphocytes. J Immunol. 139:1987;678.
7. Gay D., Maddon P., Sekaly R., Talle M.A., Godfrey M., Long E., Goldstein G., Chess C., Axel R., Kappler J., Marrack P. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature. 328:1987;626.
8. Janeway C.A. The role of CD4 in T-cell activation accessory molecule or co-receptor . Immunol Today. 10:1989;234.
9. Doyle C., Strominger J.L. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature. 330:1987;256.
10. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.C., Montagnier L. T-lymphocyte T4 molecule behave as the receptor for human retrovirus LAV. Nature. 312:1984;767.
11. Maddon P.J., Dalgleish A.G., McDougal J.S., Clapham P.R., Weiss R.A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47:1986;333.
12. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor . Science. 272:1996;872.
13. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5 a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1 . Science. 272:1996;1955.
14. Deng G., Lu Y., Zlotnikov G., Thor A.D., Smith H.S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science. 274:1996;2057.
15. Drajic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667.
16. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:1998;648.
17. Wyatt R., Kwong P.D., Desjardins E., Sweet R.W., Robinson J., Hendrickson W.A., Sodroski J.G. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 393:1998;705.
18. Bowman M.R., MacFerrin K.D., Schreiber S.L., Burakoff S.J. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules. Proc Natl Acad Sci USA. 87:1990;9052.
19. Piatier-Tonneau D., Gastinel L.N., Moussy G., Bénichou B., Amblard F., Vaigot P., Auffray C. Mutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly. Proc Natl Acad Sci USA. 88:1991;6858.
20. Houlgatte R., Scarmato P., El Marhomy S., Martin M., Ostankovitch M., Lafosse S., Vervisch A., Auffray C., Piatier-Tonneau D. HLA class II antigens and the human immunodeficiency virus envelope glycoprotein gp120 bind to the same face of CD4. J Immunol. 152:1994;4475.
21. Clayton L.K., Sieh H., Pious D.A., Reinherz E.L. Identification of human CD4 residues affecting class II MHC versus HIV gp 120 binding. Nature. 339:1989;548.
22. Moebius U., Clayton L.K., Abraham S., Diener A., Yunis J.J., Harrison S.C., Reinherz E.L. Human immunodeficiency virus gp120 binding C′C″ ridge of CD4 domain 1 is also involved in interaction with class II major histocompatibility complex molecules. Proc Natl Acad Sci USA. 89:1992;12008.
23. Moebius U., Pallai P., Harrison S.C., Reinherz E.L. Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding. Proc Natl Acad Sci USA. 90:1993;8259.
24. Lamarre D., Ashkenazi A., Fleury S., Smith D.H., Sekaly R.P., Capon D.J. The MHC-binding and gp120-binding functions of CD4 are separable. Science. 245:1989;743.
25. Fleury S., Lamarre D., Meloche S., Ryu S.E., Cantin C., Hendrickson W.A., Sekaly R.P. Mutational analysis of the interaction between CD4 and class II MHC class II antigens contact CD4 on a surface opposite the gp120-binding site . Cell. 66:1991;1037.
26. Cammarota G., Scheirle A., Takacs B., Doran D.M., Knorr R., Bannwarth W., Guardiola J., Sinigaglia F. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature. 356:1992;799.
27. König R., Huang L.Y., Germain R.N. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature. 356:1992;796.
28. Brown J.H., Jardetzky T.S., Gorga J.C., Stern L.J., Urban R.G., Strominger J.L., Wiley D.C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 364:1993;33.
29. König R., Shen X., Germain R.N. Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J Exp Med. 182:1995;779.
30. Deen C.D., McDougal J.S., Inacker R., Folena-Wasserman G., Arthos J., Rosenberg J., Maddon P.J., Axel R., Sweet R. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature. 331:1988;82.
31. Traunecker A., Schneider J., Kiefer H., Karjalainen K. Highly efficient neutralization of HIV with recombinant CD4 immunoglobulin molecules. Nature. 339:1989;68.
32. Kaiser E., Colescott R.L., Bossinger C.D., Cook P.I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem. 34:1970;595.
33. Bernstein F.C., Williams T.F., Meyer E.F., Brice M.D., Rodgers J.R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank a computer-based archival file for macromolecular structures . J Mol Biol. 112:1977;535.
34. Kraulis P.J. MOLSCRIPT a program to produce both detailed and schematic plots of protein structures . J Appl Crystallogr. 24:1991;946.
35. Autiero M., Houlgatte R., Martin M., Auffray C., Guardiola J., Piatier-Tonneau D. Competition of HLA-DR and a β2 domain peptide for human immunodeficiency virus envelope glycoprotein gp120 binding to CD4. Int Immunol. 7:1995;191.